02563.HK
Beijing Biostar Pharms Co Ltd
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 3.72
−0.27%Margins
Gross margin
92.5%
EBITDA margin
-164.2%
EBIT margin
-195.4%
Net margin
-193.0%
FCF margin
-103.8%
-16.9%
Return on equity
-14.6%
Return on assets
-17.0%
Return on invested capital
0.08x
Asset turnover
-HKD 63.6M
Cash from operations
HKD 2.38
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026